標(biāo)題: Titlebook: Antiviral Agents; Advances and Problem Shijun Ren,Eric J. Lien,Elcira C. Villarreal,E. Ju Book 2001 Springer Basel AG 2001 AIDS.Biomedicine [打印本頁(yè)] 作者: 出租車 時(shí)間: 2025-3-21 16:05
書目名稱Antiviral Agents影響因子(影響力)
書目名稱Antiviral Agents影響因子(影響力)學(xué)科排名
書目名稱Antiviral Agents網(wǎng)絡(luò)公開度
書目名稱Antiviral Agents網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Antiviral Agents被引頻次
書目名稱Antiviral Agents被引頻次學(xué)科排名
書目名稱Antiviral Agents年度引用
書目名稱Antiviral Agents年度引用學(xué)科排名
書目名稱Antiviral Agents讀者反饋
書目名稱Antiviral Agents讀者反饋學(xué)科排名
作者: accomplishment 時(shí)間: 2025-3-21 21:17 作者: 一夫一妻制 時(shí)間: 2025-3-22 00:27
Recent advances in prevention and treatment of hepatitis C virus infections,pharmacokinetic characteristics, and the discovery of novel drugs designed to inhibit the function of three major viral proteins: protease, helicase and polymerase. Finally, the HCV RNA genome itself, particularly the IRES element, is being actively exploited as an antiviral target using antisense m作者: 殘廢的火焰 時(shí)間: 2025-3-22 05:10 作者: Benign 時(shí)間: 2025-3-22 12:44 作者: 阻塞 時(shí)間: 2025-3-22 15:28
Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections,antiviral compounds targeting these proteases. This article summarizes the recent approaches in the design of novel 2A and 3C protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.作者: travail 時(shí)間: 2025-3-22 17:23 作者: Congregate 時(shí)間: 2025-3-22 23:43
https://doi.org/10.1007/978-3-322-86930-2pharmacokinetic characteristics, and the discovery of novel drugs designed to inhibit the function of three major viral proteins: protease, helicase and polymerase. Finally, the HCV RNA genome itself, particularly the IRES element, is being actively exploited as an antiviral target using antisense m作者: ANTIC 時(shí)間: 2025-3-23 01:34 作者: 表被動(dòng) 時(shí)間: 2025-3-23 07:53 作者: 抒情短詩(shī) 時(shí)間: 2025-3-23 11:28
https://doi.org/10.1007/978-3-322-86930-2antiviral compounds targeting these proteases. This article summarizes the recent approaches in the design of novel 2A and 3C protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.作者: 意見一致 時(shí)間: 2025-3-23 15:02 作者: arrhythmic 時(shí)間: 2025-3-23 19:31
0071-786X Overview: 978-3-7643-6547-9978-3-0348-7784-8Series ISSN 0071-786X Series E-ISSN 2297-4555 作者: condone 時(shí)間: 2025-3-24 01:47 作者: indoctrinate 時(shí)間: 2025-3-24 05:03 作者: 有組織 時(shí)間: 2025-3-24 09:31 作者: chandel 時(shí)間: 2025-3-24 13:00 作者: 和音 時(shí)間: 2025-3-24 15:08 作者: Spinal-Fusion 時(shí)間: 2025-3-24 21:50 作者: 薄膜 時(shí)間: 2025-3-25 02:21
Internet — Globale, multimediale Vernetzungpatients. During the past decade and a half a better understanding of the replication and disease causing state of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), varicella-zoster virus (VZV), and human cytomegalovirus (HCMV) has been achieved due in part to the development of potent antiviral作者: 時(shí)間等 時(shí)間: 2025-3-25 05:54 作者: 痛恨 時(shí)間: 2025-3-25 08:26
Progress in Drug Researchhttp://image.papertrans.cn/a/image/158700.jpg作者: etiquette 時(shí)間: 2025-3-25 13:21
https://doi.org/10.1007/978-3-030-39101-0erated, effective against all influenza types and there has been little evidence of the emergence of viral resistance. NA inhibitors provide an important new therapeutic weapon for the management of influenza infection.作者: 音樂學(xué)者 時(shí)間: 2025-3-25 18:24 作者: 龍蝦 時(shí)間: 2025-3-25 20:35 作者: 墻壁 時(shí)間: 2025-3-26 04:02 作者: bypass 時(shí)間: 2025-3-26 07:38
Recent advances in prevention and treatment of hepatitis C virus infections,anded, positive-sense RNA viruses. Upon translation of the genome, a polyprotein precursor is synthesized and further processed by both cellular and viral proteases to generate functional viral proteins. Treatment options are currently limited to the administration of α-interferon alone or in combin作者: drusen 時(shí)間: 2025-3-26 10:30 作者: prosthesis 時(shí)間: 2025-3-26 16:18 作者: FOLLY 時(shí)間: 2025-3-26 20:50 作者: 巨大沒有 時(shí)間: 2025-3-27 00:15
9樓作者: 善于 時(shí)間: 2025-3-27 01:17
9樓作者: Innocence 時(shí)間: 2025-3-27 07:50
10樓作者: Asseverate 時(shí)間: 2025-3-27 13:12
10樓作者: 鉗子 時(shí)間: 2025-3-27 14:32
10樓作者: 史前 時(shí)間: 2025-3-27 19:08
10樓
